C4 Therapeutics Lands $73,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f631cfa5-5f7f-4ac4-8de0-a02fbc6d0a91 - Date
1/8/2016 - Company Name
C4 Therapeutics - Mailing Address
Undisclosed Cambridge, MA 10018 USA - Company Description
C4 Therapeutics is developing a new class of targeted protein degradation (TPD) therapeutics for the treatment of a broad range of diseases. - Website
http://www.c4thera.com - Transaction Type
Venture Equity - Transaction Amount
$73,000,000 - Transaction Round
Series A - Proceeds Purposes
The Company is developing novel treatments in the field of targeted protein degradation using proprietary Degronimid technology. - M&A Terms
- Venture Investor
Cobro Ventures - Venture Investor
Cormorant Asset Management - Venture Investor
The Kraft Group
